Please provide your email address to receive an email when new articles are posted on . The integration of second-generation anti-vascular endothelial growth factor (VEGF) therapies into treatment ...

Measuring macular neovascularization vessel density with OCT-A at the time of anti-VEGF treatment cessation helps estimate the risk of later nAMD recurrence. Higher macular neovascularization (MNV) ...

PORTLAND, Maine--(BUSINESS WIRE)--BerryDunn, a full-service accounting, tax, and consulting firm, will return for the 20 th year to the National Association of Medicaid Directors Fall Conference (NAMD ...

BerryDunn, a full-service accounting, tax, and consulting firm, will return for the 20th year to the National Association of Medicaid Directors Fall Conference (NAMD), taking place in National Harbor, ...

Make sure not to miss this valuable item your first time around. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Add us as a preferred source on ...

The study examined patients who were treated with intravitreal anti-vascular endothelial growth factor (anti-VEGF) compounds for their nAMD. A total of 76 patients (92 eyes) were followed for at least ...

Roche (RHHBY) announced new data from two studies on ophthalmology drug Vabysmo (faricimab). Vabysmo is already approved in several countries for people with neovascular or ‘wet’ age-related macular ...

Company to present topline 40-week Phase 2 study efficacy and safety results of migaldendranib (MGB), a novel first-in-class nanomedicine for DME and nAMD Subcutaneous at-home administration ...

Microsoft is betting big on AI. Starting with integrating Bing with ChatGPT, it has implemented AI capabilities in its products. Microsoft Designer is a new product from Microsoft with AI capabilities ...

Purpose To explore the association between early response of different lesions and the number of anti-vascular endothelial growth factor (anti-VEGF) injections in neovascular age-related macular ...

Neovascular age-related macular degeneration (nAMD) is a progressive eye disease characterized by choroidal neovascularization and subretinal hemorrhage and exudation, leading to vision impairment.

Researchers evaluated the efficacy, safety, and durability of the port-delivery system with ranibizumab in real-world patients with neovascular age-related macular degeneration. The port-delivery ...